Sonoma Pharmaceuticals partners with Kenvue Brands for US manufacturing and supply of Microcyn technology products

fr.investing.com (French)

Sonoma Pharmaceuticals signed a manufacturing and supply agreement with Kenvue Brands for Microcyn technology products in the US. The deal, effective October 24, 2025, runs until March 2027 with potential one-year extensions. Sonoma will produce and supply products for Kenvue's US market sales. This follows Sonoma's recent US commercial launch of its hypochlorous acid-based burn relief hydrogel and the introduction of the Aquanil AD product line.


With a significance score of 1.5, this news ranks in the top 37% of today's 32913 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: